About Pulvinar Neuro
Pulvinar Neuro is a Healthcare company based in Durham (United States) founded in 2016, and was acquired by Alpha-Stim in March 2022. Drugs for neuroscience research are developed and services provided. Pulvinar Neuro offers products and services including XCSITE-RD and Next-Generation Brain Stimulation Devices. Its focus areas include Traditional Pharmaceuticals. Its legal entity is PulvinarNeuro Inc.
Company details
Pulvinar Neuro was established in 2016 in Durham, United States. Focus is placed on the biotechnology sector, where drugs targeting neuroscience conditions are developed. Research services are offered to support scientific investigations in this field. Operations center on advancing therapeutic solutions for neurological applications, with activities conducted primarily in the United States. The companys domain, pulvinarneuro.com, facilitates access to these resources.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website pulvinarneuro.com
- Social LinkedIn X
- Acquired by Alpha-Stim (Mar 2022)
- Legal Name Pulvinarneuro Inc.
- Latest Funding Round$55K (USD), Grant
Sep 2021
- InvestorsHHS
& 1 more
- Acquired byAlpha-Stim
(Mar 2022)
Products & Services of Pulvinar Neuro
Pulvinar Neuro offers a comprehensive portfolio of products and services, including XCSITE-RD and Next-Generation Brain Stimulation Devices.
A transcranial stimulation device is offered for double-blind research in tDCS and tACS applications.
Advanced devices are provided that enable custom waveforms and feedback-controlled stimulation based on EEG features for research purposes.
Funding Insights of Pulvinar Neuro
- Total Rounds 2
- Last Round Grant — $55,000
- First Round $3.34M
(Sep 2019)
- Investors Count 1
All 2 funding rounds of Pulvinar Neuro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Pulvinar Neuro
Pulvinar Neuro has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Alpha-Stim.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Non-drug electrotherapy devices for pain and anxiety are developed. | 1996 | alpha-stim.com | Texas City, United States |
Investor details for Pulvinar Neuro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pulvinar Neuro
2 people are tracked at Pulvinar Neuro (2 in team).
| Name | Role | Group |
|---|---|---|
Isaac Shaw | Engineer II | Team |
James McCall | Principal Engineer | Team |
Complete people profiles for Pulvinar Neuro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pulvinar Neuro
4 dated milestones of Pulvinar Neuro across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Pulvinar Neuro is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Grant, of $55K.
- Exit Acquired by Alpha-Stim.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Pulvinar Neuro (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pulvinar Neuro
Pulvinar Neuro was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Pulvinar Neuro is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Pulvinar Neuro was established in 2016 in Durham, United States. Focus is placed on the biotechnology sector, where drugs targeting neuroscience conditions are developed. Research services are offered to support scientific investigations in this field. Operations center on advancing therapeutic solutions for neurological applications, with activities conducted primarily in the United States. The companys domain, pulvinarneuro.com, facilitates access to these resources.
Pulvinar Neuro offers XCSITE-RD and Next-Generation Brain Stimulation Devices.
Pulvinar Neuro has 2 investors. Key investors include HHS, and Alpha-Stim.
Pulvinar Neuro operates through Pulvinarneuro Inc..
Yes. Pulvinar Neuro was acquired by Alpha-Stim in March 2022.